soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results Emily Kronau, PharmD, MBA (@Phar_em_D)

13: Patients with a particularly deadly cancer got their first new frontline treatment in more than a decade as the FDA approved Ipsens Onivyde, along with three chemo drugs, for metastatic pancreatic adenocarcinoma (mPDAC)

PERFECT FOR ON-THE-GO: The compact packaging of these oral dissolving films makes them ideal for busy lifestyles, allowing you to enjoy skin benefits anytime, anywhere.

The strawberry option specifically lists milk and egg in the protein components, which matters a lot for anyone avoiding those

Morgan analysts told CNBC that the results were disappointing, but they see potential for amylin analog drug groups for obesity treatment

5) patients with severe gastrointestinal dysfunction